Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Volkswagen in talks with defence firms on use of Germany plant: CEO - 2Find the Insider facts of Compelling Systems administration: Building Associations for Progress
- 3'Malcolm in the Middle' reboot releases 1st trailer, reuniting Frankie Muniz and Bryan Cranston: Watch here
- 4Health officials report 14 Legionnaires' disease cases in Florida, gym connection suspected
- 5In the stomach of a mummified wolf pup, scientists find DNA from a woolly rhinoceros
- US bishops officially ban gender-affirming care at Catholic hospitals
- Beyond oil: The crucial exports blocked by Hormuz closure
- Wegmans recalls mixed nuts over salmonella contamination fears
- Ukraine proved this drone-killer works. Now, the West is giving it a shot.
- Genome study reveals milestone in history of cat domestication
- The Best Computer games Ever
- Nestlé says 413,793 KitKat candy bars stolen en route from Italy to Poland
- Top Pastry: What's Your Sweet Treat of Decision?
- Woman shocked to welcome baby after experiencing stomach pain on Christmas
